WelbeHealth Administers First Shipment of COVID-19 Vaccines to Most Vulnerable Seniors by Carolyn Helms | Dec 31, 2020 | Portfolio News
Orbus Therapeutics Receives U.S. Patent for Eflornithine Formulations by Carolyn Helms | Dec 23, 2020 | Portfolio News
Vaxcyte Promotes Andrew Guggenhime to President and Chief Financial Officer by Carolyn Helms | Dec 22, 2020 | Portfolio News
European Commission Approves Aimmune’s PALFORZIA® as First-Ever Treatment for Peanut Allergy in the EU by Carolyn Helms | Dec 21, 2020 | Portfolio News
Neurana Pharmaceuticals Announces First Patient Enrolled in Phase 3, RESUME-1 Study by Carolyn Helms | Dec 21, 2020 | Portfolio News
